Status:
COMPLETED
HFR Cartridge and Inflammation
Lead Sponsor:
Federico II University
Conditions:
Inflammatory Status
P-cresol
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
A major limitation of standard hemodialysis is that it does not clear the plasma from interleukin-6 (IL-6) and p-cresol, two uremic toxins responsible for the high cardiovascular risk in end stage ren...
Eligibility Criteria
Inclusion
- HD patients undergoing three weekly haemodialysis \> 1 year
Exclusion
- none
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01865773
Start Date
January 1 2011
End Date
September 1 2012
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
federico II university, department of nephrology
Naples, Naples, Italy, 80129